AffinityAI ApS provides AI-powered protein binders called Designerbodies™ for research.
AffinityAI ApS has raised $646K in total funding. The most recent round was Pre-Seed. The last funding was announced in September 2026.
AffinityAI ApS's investors include BioInnovation Institute Venture Lab.
AffinityAI ApS is headquartered in Copenhagen, Denmark.
AffinityAI ApS provides AI-powered protein binders called Designerbodies™ for research.
AffinityAI ApS is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"AffinityAI ApS — Funding & Investors." VCBacked, September 16, 2026, https://www.vcbacked.co/company/affinityai-aps. Accessed October 1, 2026.
VCBacked. (2026). AffinityAI ApS — Funding & Investors. Retrieved October 1, 2026, from https://www.vcbacked.co/company/affinityai-aps
{{cite web |title=AffinityAI ApS — Funding & Investors |url=https://www.vcbacked.co/company/affinityai-aps |website=VCBacked |access-date=October 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated